Objectives: To assess the long-term survival, health-related quality of life, and quality-adjusted life years of cancer patients admitted to ICUs. Design: Prospective cohort. Setting: Two cancer specialized ICUs in Brazil. Patients: A total of 792 participants. Interventions: None. Measurements and Main Results: The health-related quality of life before ICU admission; at 15 days; and at 3, 6, 12, and 18 months was assessed with the EQ-5D-3L. In addition, the vital status was assessed at 24 months. The mean age of the subjects was 61.6 +/- 14.3 years, 42.5% were female subjects and half were admitted after elective surgery. The mean Simplified Acute Physiology Score 3 was 47.4 +/- 15.6. Survival at 12 and 18 months was 42.4% and 38.1%, respectively. The mean EQ-5D-3L utility measure before admission to the ICU was 0.47 +/- 0.43, at 15 days it was 0.41 +/- 0.44, at 90 days 0.56 +/- 0.42, at 6 months 0.60 +/- 0.41, at 12 months 0.67 +/- 0.35, and at 18 months 0.67 +/- 0.35. The probabilities for attaining 12 and 18 months of quality-adjusted survival were 30.1% and 19.1%, respectively. There were statistically significant differences in survival time and quality-adjusted life years according to all assessed baseline characteristics (ICU admission after elective surgery, emergency surgery, or medical admission; Simplified Acute Physiology Score 3; cancer extension; cancer status; previous surgery; previous chemotherapy; previous radiotherapy; performance status; and previous health-related quality of life). Only the previous health-related quality of life and performance status were associated with the health-related quality of life during the 18-month follow-up. Conclusions: Long-term survival, health-related quality of life, and quality-adjusted life year expectancy of cancer patients admitted to the ICU are limited. Nevertheless, these clinical outcomes exhibit wide variability among patients and are associated with simple characteristics present at the time of ICU admission, which may help healthcare professionals estimate patients' prognoses. Copyright (C) by 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1pwB8AR
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
This feed no longer exists. Cambridge Journals Online and Cambridge Books Online have been replaced by Cambridge University Press’s new acad...
-
Abstract In this work, novel thin-film composite forward osmosis (TFC-FO) hollow fiber membranes were fabricated by modifying polyamide ac...
-
Objectives: Opioids and benzodiazepines are commonly used to provide analgesia and sedation for critically ill children with cardiac disease...
-
Objective: Inotropic and vasopressor drugs are routinely used in critically ill patients to maintain adequate blood pressure and cardiac ou...
-
Academic Emergency Medicine, EarlyView. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2Lq7OXW
-
Abstract The dispersion properties of Love waves are utilized for the fabrication of sensor devices in the different material environments...
-
Abstract Background and Significance Adverse drug events (ADEs) occur in approximately 2–5% of hospitalized patients, often resulting in...
-
Plasminogen activator inhibitor-1 gene polymorphisms in systemic lupus erythematosus: is there a risk for lupus nephritis among Egyptians? A...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου